GSC
WGS icon

Ground Swell Capital’s GeneDx Holdings WGS Stock Holding History

Ground Swell Capital’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,654
Closed -$286K – 189
2025
Q3 		$286K Buy
+2,654
New +$289K 0.63% 59

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ground Swell Capital's WGS Position: Q4 2025 in Review

Ground Swell Capital sold out of GeneDx Holdings (WGS) in Q4 2025, closing a stake of 2,654 shares — an estimated $286K sold.

Ground Swell Capital first reported a position in WGS in Q3 2025 and held it in 1 quarter. The position peaked at $286K in Q3 2025. 286 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Ground Swell Capital reported no remaining GeneDx Holdings position as of Q4 2025 after selling out during the quarter.
  • Ground Swell Capital sold 2,654 GeneDx Holdings shares in Q4 2025, an estimated $286K.
  • Ground Swell Capital first reported a position in GeneDx Holdings in Q3 2025 and held it in 1 quarter.
  • Ground Swell Capital's GeneDx Holdings position peaked at $286K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Ground Swell Capital's 13F filing for Q4 2025, filed 4 Feb 2026.